Welcome to our dedicated page for Jefferson Capital SEC filings (Ticker: JCAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jefferson Capital, Inc. (NASDAQ: JCAP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its activities as an analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts. These SEC filings cover its operations in the United States, Canada, the United Kingdom and Latin America, and describe its work with secured and unsecured consumer receivables originated by banks, non-bank consumer lenders, auto finance companies, utilities, telecommunications providers, credit card issuers and fintech origination platforms.
On this page, you can review Jefferson Capital’s current reports on Form 8-K, which disclose material events such as quarterly financial results, asset purchase agreements and amendments to its senior secured revolving credit facility. For example, Form 8-K filings describe the asset purchase agreement to acquire a credit card receivables portfolio from affiliates of Bluestem Brands and the amendment that increased aggregate commitments and extended the maturity of the company’s revolving credit facility.
In addition to 8-Ks, Jefferson Capital’s registration statements, such as Form S-1, and periodic reports on Form 10-Q and other filings discuss risk factors, leverage, liquidity, capital resources and non-GAAP financial measures used by management. These documents explain how the company funds portfolio purchases, manages its credit facility covenants and evaluates collections and estimated remaining collections on its receivables portfolios.
Stock Titan’s SEC filings page for JCAP provides real-time access to new filings as they are posted to EDGAR, along with AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify disclosures on portfolio acquisitions, financing arrangements, quarterly and annual results, and other regulatory information relevant to Jefferson Capital’s receivables management business.
OROS JOHN J reported acquisition or exercise transactions in this Form 4 filing.
Jefferson Capital director John J. Oros received two stock option grants as compensation. On March 11, 2026, he was awarded options covering 25,000 shares of common stock at $20.78 per share and another 25,000 shares at $34.78 per share, each expiring on March 10, 2036.
The filing shows 25,000 derivative shares reported as beneficially owned following each transaction entry, indicating these are new grants rather than sales. A footnote explains the options vest in three equal annual installments, subject to Mr. Oros continuing to serve through each vesting date.
Jefferson Capital, Inc. files its annual report describing a global business that buys and services nonperforming consumer receivables across the U.S., Canada, the U.K. and Latin America. The company purchases charged-off and distressed portfolios, then collects through legal and call-center channels and third-party agencies.
In June 2025, Jefferson Capital completed an IPO in which selling shareholders sold 10,875,000 shares at $15.00 per share and the company issued 625,000 shares, generating net proceeds of $4.5 million. As of June 30, 2025, common stock held by non-affiliates had an aggregate market value of $316.0 million, and as of March 12 there were 55,329,124 shares outstanding.
The report highlights a $196.3 million purchase of Bluestem credit card assets, with estimated remaining collections of $295.6 million, and discusses prior Conn’s portfolio purchases. Extensive risk disclosures cover economic downturns, concentration in a few large sellers, regulatory and litigation exposure, international and tax changes, reliance on outsourcing (including operations in Mumbai), and growing cybersecurity and data privacy obligations under regimes such as CFPB rules, GDPR and CCPA.
Jefferson Capital, Inc. reported strong fourth quarter and full year 2025 results, highlighted by record performance across key metrics. Fourth quarter collections rose to
Estimated remaining collections reached
For full year 2025, total revenues increased to
Recent developments include the closing of the Bluestem portfolio purchase on
Jefferson Capital, Inc. disclosed that investor David M. Burton beneficially owned 3,777,500 shares of its common stock as of June 30, 2025, representing 5.8% of the outstanding shares based on 64,685,082 shares then outstanding. Burton had sole voting and dispositive power over these shares.
The filing notes that 385,000 shares of common stock were sold on January 9, 2026, after which Burton’s beneficial ownership decreased to 5.5% of Jefferson Capital’s outstanding common stock, based on 61,629,228 shares outstanding as of January 8, 2026. The position is held directly in Burton’s name, and no group or additional controlling entities are identified.
Jefferson Capital, Inc. director and Chief Executive Officer and President David M. Burton reported a sale of common stock. On January 9, 2026, he sold 385,000 shares of Jefferson Capital common stock at $20.50 per share, coded as an open market or similar sale ("S").
According to the footnote, this represents the sale of shares to the underwriters in the issuer's secondary offering, rather than ordinary open-market trading. After this transaction, Burton beneficially owned 3,392,500 shares of Jefferson Capital common stock in direct form.
JCF IV JCAP Holding L.P. and affiliated JCF entities reported a large secondary sale of Jefferson Capital, Inc. (JCAP) common stock. On January 9, 2026, they sold 11,000,000 shares of common stock at a sale price of $19.6288 per share in a secondary offering that closed that day. Following this transaction, the filing reports that 32,721,808 shares of Jefferson Capital common stock were beneficially owned on an indirect basis.
The securities in this transaction are held directly by JCF IV JCAP Holding L.P., with a chain of general partners and controlling entities including JCF IV JCAP Holding GP LLC, JCF Associates IV L.P., JCF Associates IV Ltd., and J. Christopher Flowers. The reporting persons state that they disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest.
Jefferson Capital, Inc. reported strong Q3 2025 results, driven by portfolio income and servicing growth. Total Q3 revenues were $150,842 thousand, up from $110,601 thousand last year, with net income of $38,362 thousand. Nine‑month revenues reached $458,490 thousand and net income $150,234 thousand, reflecting higher collections and expanded servicing activity.
Total assets were $1,802,921 thousand, including $1,640,809 thousand of investments in receivables, net. Notes payable, net, were $1,182,584 thousand, with senior unsecured notes due 2026, 2029 and 2030 outstanding and the revolving credit facility at zero at quarter‑end. Operating cash flow for the nine months was $193,645 thousand. Following the June 2025 IPO, common shares outstanding were 58,290,473 as of November 14, 2025, and year‑to‑date dividends totaled $0.74 per share. The December 2024 Conn’s portfolio purchase totaled $244,937 thousand and contributed revenue and income in 2025.
Jefferson Capital, Inc. announced its financial results for the quarter ended September 30, 2025, and furnished the related press release via an Item 2.02 Form 8-K.
The press release is included as Exhibit 99.1 and is furnished, not filed, which means it is not subject to Section 18 liability and is not incorporated by reference unless specifically stated. The company’s common stock trades on the Nasdaq Global Select Market under the ticker JCAP.
Jefferson Capital, Inc. announced an agreement for its subsidiary to acquire certain Bluestem credit card assets for $302.8 million, including a revolving receivables portfolio where new draws have been suspended, plus related IP, records, bank accounts used for collections, and specified contracts. A $20.0 million escrow secures implementation obligations. At the June 30, 2025 cut-off date, the receivables had an aggregate face value of approximately $488.2 million. The company does not intend to pursue ongoing originations through the Bluestem platform, and no Bluestem retail operations are included.
Servicing will transition to CardWorks Servicing, LLC. Closing is subject to customary conditions, including HSR waiting period expiration, and is expected in the fourth quarter of 2025.
Separately, the company amended its credit facility: aggregate commitments increased by $175 million to $1.0 billion, interest margins were reduced by 50 basis points, non-use fees were trimmed with a 35 bps cap, credit spread adjustments were eliminated, and maturity was extended to October 27, 2030 with a springing maturity tied to existing senior notes. The amendment also adjusts permitted distributions, removes a minimum tangible net worth covenant, and updates audit/exam provisions.
Jefferson Capital, Inc. (JCAP) received an initial Form 3 disclosing that JCF IV JCAP Holding L.P. indirectly holds 43,721,808 shares of the issuer's common stock following an internal reorganization on 08/22/2025. The filing states that J.C. Flowers IV L.P. contributed 13,492,856 shares and JCF IV Coinvest JCAP L.P. contributed 30,228,952 shares to JCF IV JCAP Holding L.P. for no consideration.
The shares held by the holding entity are subject to a lock-up agreement with the underwriters from the issuer's recent IPO. JCF IV JCAP Holding GP LLC is the general partner of the holding limited partnership, and J. Christopher Flowers is identified as the ultimate controller of the related entities. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.